GlassScriptPhysician profile
Deann M Green
NPI 1982659207
$3,385.82
in general payments reported to CMS, 2019-2025
40 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $192 · 2022: $933 · 2023: $795 · 2024: $316 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.90 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $322.11 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $318.33 | 2019-2023 | Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $278.45 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $242.07 | 2019-2024 | |
| Amgen INC. | $214.42 | 2019-2024 | Evenity, Prolia |
| Myriad Women'S Health, INC. | $205.48 | 2023 | Myrisk |
| Organon LLC | $159.83 | 2022-2025 | Nexplanon, Jada System |
| Roche Diagnostics Corporation | $133.17 | 2019-2020 | |
| Hologic Sales and Service, LLC | $113.30 | 2019-2023 | Novasure, Aptima |
| Myovant Sciences INC. | $98.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.02 | 2019-2025 | |
| Scynexis, INC. | $89.10 | 2022 | |
| Urovant Sciences INC | $85.07 | 2022 | |
| Mayne Pharma Commercial LLC | $80.34 | 2022-2023 | |
| Daiichi Sankyo INC. | $75.78 | 2019-2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $64.02 | 2022-2025 | Hemosphere |
| Mylan Pharmaceuticals INC. | $63.43 | 2019-2022 | |
| Shield Therapeutics INC | $59.86 | 2023-2025 | Accrufer |
| Sage Therapeutics, LLC | $54.11 | 2019-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $49.44 | 2020-2022 | |
| Exeltis, USA INC. | $47.22 | 2022-2025 | Slynd |
| Coopersurgical, INC. | $46.17 | 2019-2020 | |
| Avion Pharmaceuticals | $45.28 | 2019-2022 | |
| Minerva Surgical, INC | $44.87 | 2019-2023 | |
| Millicent US INC | $43.38 | 2023-2024 | Intrarosa |
| Allergan, INC. | $37.16 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $35.56 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.95 | 2022 | |
| Duchesnay USA Incorporated | $28.41 | 2019 | |
| Therapeuticsmd, INC. | $27.01 | 2019-2022 | |
| Caldera Medical, INC | $26.45 | 2023 | Desara |
| Amag Pharmaceuticals, INC. | $26.11 | 2019-2020 | |
| Kci USA, INC. | $24.20 | 2019 | |
| Axonics, INC. | $20.87 | 2023 | Axonics |
| Solventum Corporation | $19.64 | 2025 | Prevena |
| Supernus Pharmaceuticals, INC. | $17.99 | 2025 | Qelbree |
| Teleflex LLC | $17.36 | 2025 | Quikclot |
| Intuitive Surgical, INC. | $17.11 | 2019 | |
| Atland Pharmaceuticals, LLC | $14.84 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Vertical Pharmaceuticals, LLC | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deann Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.